A new solution for the efficient transportation and storage of ultra-cold biologics, such as Covid-19 vaccines, has been launched by South African helium and natural gas company Renergen.
Called the Cryo-Vacc™, the solution has a temperature range of -150°C to 8°C, making it highly versatile for a range of vaccines that need to be transported for up to 25 days or longer in transit, where access to an external power source is not possible.
Renergen yesterday (15th Feb) announced the completion and successful operation of its first Cryo-Vacc™ prototype, which was presented to South African-based media at the company’s headquarters in Johannesburg.
Sharing details of the solution, Renergen said Cryo-Vacc™ is ideal for both air and ground transportation, utilising liquid nitrogen to transport by road and helium to transport by air.
... to continue reading you must be subscribed
